| Probiotics promote gut health through stimulation of epithelial innate immunity C Pagnini, R Saeed, G Bamias, KO Arseneau, TT Pizarro, F Cominelli Proceedings of the national academy of sciences 107 (1), 454-459, 2010 | 441 | 2010 |
| Diet supplementation, probiotics, and nutraceuticals in SARS-CoV-2 infection: a scoping review F Infusino, M Marazzato, M Mancone, F Fedele, CM Mastroianni, ... Nutrients 12 (6), 1718, 2020 | 217 | 2020 |
| Comparison of three different risk scoring systems in non-variceal upper gastrointestinal bleeding L Camellini, A Merighi, C Pagnini, F Azzolini, S Guazzetti, A Scarcelli, ... Digestive and liver disease 36 (4), 271-277, 2004 | 119 | 2004 |
| Novel pharmacological therapy in inflammatory bowel diseases: beyond anti-tumor necrosis factor C Pagnini, TT Pizarro, F Cominelli Frontiers in Pharmacology 10, 445793, 2019 | 70 | 2019 |
| The Th1 immune pathway as a therapeutic target in Crohn's disease. G Bamias, K Sugawara, C Pagnini, F Cominelli Current Opinion in Investigational Drugs (London, England: 2000) 4 (11 …, 2003 | 62 | 2003 |
| Mucosal adhesion and anti-inflammatory effects of Lactobacillus rhamnosus GG in the human colonic mucosa: A proof-of-concept study C Pagnini, VD Corleto, M Martorelli, C Lanini, G D’Ambra, E Di Giulio, ... World Journal of Gastroenterology 24 (41), 4652, 2018 | 61 | 2018 |
| Eczema and food allergy in an Italian pediatric cohort: no association with TLR-2 and TLR-4 polymorphisms E Galli, A Ciucci, S Cersosimo, C Pagnini, S Avitabile, G Mancino, ... International Journal of Immunopathology and Pharmacology 23 (2), 671-675, 2010 | 54 | 2010 |
| Alteration of local microflora and α-defensins hyper-production in colonic adenoma mucosa C Pagnini, VD Corleto, ML Mangoni, E Pilozzi, MS Torre, R Marchese, ... Journal of clinical gastroenterology 45 (7), 602-610, 2011 | 50 | 2011 |
| Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) G Fiorino, F Caprioli, M Daperno, F Mocciaro, M Principi, A Viscido, ... Digestive and Liver Disease 51 (5), 632-639, 2019 | 40 | 2019 |
| Proposal of a new clinical index predictive of endoscopic severity in ulcerative colitis F Azzolini, C Pagnini, L Camellini, A Scarcelli, A Merighi, AM Primerano, ... Digestive diseases and sciences 50, 246-251, 2005 | 35 | 2005 |
| Natalizumab in the treatment of Crohn’s disease patients C Pagnini, KO Arseneau, F Cominelli Expert opinion on biological therapy 17 (11), 1433-1438, 2017 | 29 | 2017 |
| Endoscopic scores for inflammatory bowel disease in the era of ‘mucosal healing’: Old problem, new perspectives C Pagnini, F Menasci, F Desideri, VD Corleto, G Delle Fave, E Di Giulio Digestive and Liver Disease 48 (7), 703-708, 2016 | 29 | 2016 |
| Enteropathic spondyloarthritis: results from a large nationwide database analysis A Picchianti-Diamanti, R Lorenzetti, MS Chimenti, MM Luchetti, ... Autoimmunity Reviews 19 (2), 102457, 2020 | 21 | 2020 |
| IL-1β-511 and IL-1RN* 2 polymorphisms in inflammatory bowel disease: An Italian population study and meta-analysis of European studies VD Corleto, C Pagnini, G Margagnoni, D Guagnozzi, MS Torre, ... Digestive and Liver Disease 42 (3), 179-184, 2010 | 21 | 2010 |
| Outcome and risk of recurrence for endoscopic resection of colonic superficial neoplastic lesions over 2 cm in diameter G Margagnoni, S Angeletti, G D’Ambra, C Pagnini, M Ruggeri, VD Corleto, ... Digestive and Liver Disease 48 (4), 399-403, 2016 | 19 | 2016 |
| Systematic review with network meta-analysis: efficacy of induction therapy with a second biological agent in anti-TNF-experienced Crohn’s disease patients C Pagnini, SI Siakavellas, G Bamias Gastroenterology Research and Practice 2018, 2018 | 18 | 2018 |
| Real-life efficacy and safety of ustekinumab as second-or third-line therapy in Crohn’s disease: results from a large Italian cohort study A Tursi, G Mocci, A Cuomo, L Allegretta, G Aragona, R Colucci, ... European Review for Medical and Pharmacological Sciences 25 (4), 2099-2108, 2021 | 17 | 2021 |
| Comparison of performances of adalimumab biosimilars SB5, ABP501, GP2017, and MSB11022 in treating patients with inflammatory bowel diseases: a real-life, multicenter … A Tursi, G Mocci, L Allegretta, G Aragona, MA Bianco, R Colucci, ... Inflammatory Bowel Diseases 29 (3), 376-383, 2023 | 15* | 2023 |
| A case of oesophageal ulcer developed after taking homeopathic pill in a young woman VD Corleto, L D’Alonzo, E Zykaj, A Carnuccio, F Chiesara, C Pagnini, ... World journal of gastroenterology: WJG 13 (14), 2132, 2007 | 15 | 2007 |
| Mayo endoscopic score and ulcerative colitis endoscopic index are equally effective for endoscopic activity evaluation in ulcerative colitis patients in a real life setting C Pagnini, MC Di Paolo, BM Mariani, R Urgesi, L Pallotta, MA Vitale, ... Gastroenterology insights 12 (2), 217-224, 2021 | 14 | 2021 |
